MSN: Combo therapy for head and neck cancer

UC researchers have tested a new combination therapy that showed reduced growth of head and neck cancer in an animal-based study. These results were published in the journal Cancer Letters.

Christina Wicker, PhD, a postdoctoral fellow in the lab of Vinita Takiar, MD, PhD, led this research and says head and neck cancer is the sixth most common cancer worldwide.

“Head and neck cancer, like any cancer, is truly life-altering. Head and neck cancer could impact your throat, tongue or nose and patients often can’t swallow, talk or eat; it truly takes away some of the most social, enjoyable parts of life,” she says.

“Until now, no one has examined if this drug has the potential to improve radiation treatment in head and neck cancer.”

Read the full MSN article.

Read the UC News story about Wicker’s research.

Featured photo of Christina Wicker working in the lab by Colleen Kelley.

/University Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.